✦ LIBER ✦

Interferon/long-term lamivudine combination therapy in anti-HBe positive chronic hepatitis B patients

✍ Scribed by NIKOLAOS L NIKOLAIDIS; OLGA I GIOULEME; KONSTANTINOS A TZIOMALOS; ADAMOS S SAVERIADIS; NIKOLAOS GRAMMATIKOS; PANAGIOTIS DOUKELIS; ANASTASIOS D VOUTSAS; THEMISTOKLIS VASSILIADIS; KALLIOPI PATSIAOURA; ELENI ORFANOU-KOUMERKERIDOU; AIKATERINI BALASKA; NIKOLAOS P EUGENIDIS

Book ID: 108950475
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 64 KB
Volume: 20
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2005.04029.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term follow-up of anti-HBe-positive

Long-term follow-up of anti-HBe-positive chronic active hepatitis B

✍ Giovanna Fattovich; Lucio Brollo; Alfredo Alberti; Patrizia Pontisso; Giuliano G 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 2 views

Twenty-eight patients with chronic active hepatitis without cirrhosis who were positive for hepatitis B surface antigen and antibody to hepatitis B e antigen were followed for 1 to 15 years (mean 6.6 years) and underwent follow-up biopsy. At presentation, 12 of the 28 patients (43%) had hepatitis B

Low-dose recombinant interferon therapy

Low-dose recombinant interferon therapy in anti-HBe-positive chronic hepatitis B in Asian Indians

✍ RAJ KUMAR C GUPTAN; VARSHA THAKUR; VEENA MALHOTRA; SHIV K SARIN 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB

Long-term lamivudine therapy for childre

Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B

✍ Etienne M. Sokal; Deirdre A. Kelly; Jacek Mizerski; Isabel B. Badia; Jorge A. Ar 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

One year of lamivudine treatment results in increased hepatitis B e antigen (HBeAg) seroconversion and serum hepatitis B virus (HBV) DNA negativity in children with chronic hepatitis B and high serum alanine aminotransferase concentrations. Two hundred seventy-six children who participated in a 1-ye

Interferon vs. adenine arabinoside 5′-mo

Interferon vs. adenine arabinoside 5′-monophosphate in patients with anti-HBe-positive chronic hepatitis

✍ Buti, Maria; Jardi, Rosendo; Rodriguez-Frias, Francisco; Allende, Helena; Cotrin 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB 👁 1 views

Anti-HBe-positive patients with precore mutants may have severe, progressive liver disease. Therapy with interferon has been effective, but relapses are frequent. To evaluate and compare two antiviral treatments, lymphoblastoid interferon fly-IFN) and adenine arabinoside 5'-monophosphate (ARA-AMP),

Long-term follow-up of peginterferon and

Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B

✍ Henry Lik-Yuen Chan; Alex Yui Hui; Vincent Wai-Sun Wong; Angel Mei-Ling Chim; Ma 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

We have previously demonstrated that combination peginterferon and lamivudine treatment has superior antiviral efficacy to lamivudine monotherapy in chronic hepatitis B. In this study, we investigated the long-term posttreatment virological response to this combination treatment. Sustained virologic

Combination therapy of lamivudine and ad

Combination therapy of lamivudine and adefovir in Japanese patients with chronic hepatitis B

✍ Satoshi Shakado; Hiroshi Watanabe; Takashi Tanaka; Daisuke Morihara; Shinya Nish 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 251 KB